Efficacy of pregabalin for post-operative pain in patients with soft tissue sarcoma arising in lower extremities.

Efficacy of pregabalin for post-operative pain in patients with soft tissue sarcoma arising in lower extremities. - Efficacy of pregabalin for post-operative pain for lower exterimity soft tissue sarcoma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020558

Enrollment

Registered

2016-01-14

Start date

2013-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft tissue sarcoma

Interventions

pregabalin(75mgx2/day)+Lorcam(4mgx3/day) from day3 after surgery to 14 days after surgery Lorcam(4mgx3/day) from day3 after surgery to 14 days after surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with soft tissue sarcoma of lower extermity, who require surgical treatment

Exclusion criteria

Exclusion criteria: patients with renal dysfunction, gastric ulcer, pregnancy, heart disease patients who was considered inadequate by a physician in charge

Design outcomes

Primary

Measure	Time frame
pain VAS at 2 weeks after surgery	—

Secondary

Measure	Time frame
pain VAS at 4 weeks after surgery sleep VAS at 1, 2, and 4 weeks after surgery painDETECT at 1, 2, 4 weeks after surgery	—

Countries

Japan

Contacts

Public ContactYoshihiro Nishida

Nagoya University Graduate School of Medicine Orthopaedic Surgery

ynishida@med.nagoya-u.ac.jp052-741-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026